Janssen’s COVID-19 vaccine to be introduced to South Korea in the second quarter has officially requested for authorization to the Ministry of Food and Drug Safety (MFDS). Following AstraZeneca and Pfizer, the multinational company would be a third company to apply for the authorization on COVID-19 vaccine in the country.

On Feb. 27, MFDS official announced Janssen (Johnson & Johnson) has submitted an application for approval on COVID-19 vaccine (code name: Ad26.COV2S).

The vaccine was one of a part the South Korean government’s vaccination plan. While AstraZeneca and Pfizer’s vaccines need double doses for a full vaccination, Janssen’s vaccine only requires single dose and the gov